Rui Cruz Ferreira

Rui Cruz Ferreira

Auto-generated profile, based on publicly available information

Rui Cruz Ferreira

Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2014 in European Heart Journal: Acute Cardiovascular Care
Verified
Journal Article
Open access
PDF file
ATAna T Timóteo
Ana T Timóteo
APAna L Papoila
Ana L Papoila
PRPedro Rio
Pedro Rio
FMFernando Pellon de de Miranda
Fernando Pellon de de Miranda
MFMaria Lujan Ferreira
Maria Lujan Ferreira
RFRui C Ferreira
Rui C Ferreira
Background: Abnormal glucose metabolism is a predictor of worse outcome after acute coronary syndrome (ACS). However, this parameter is not included in risk prediction scores, including GRACE risk score. We sought to evaluate whether the inclusion of blood glucose at admission in a model with GRACE risk score improves risk stratification. Methods: Study of consecutive patients included in a single centre registry of ACS. Our primary endpoint was the occurrence of all-cause mortality at one-year follow-up. The ability of the two logistic regression models (GRACE risk score alone and in combination with blood glucose) to predict death was analysed. Continuous net reclassification improvement (NRI) and integrated discrimination improvement (IDI), with corresponding 95% confidence intervals (CIs), were also calculated. Results: We included 2099 patients, with a mean age of 64 (SD=13) years, 69% males. In our sample, 55.1% presented with ST-segment elevation ACS and 13.1% in Killip class ≥ 2. Only 25% were known diabetic at admission. In-hospital mortality was 5.8% and 9.7% at one-year follow-up. The best cut-point for blood glucose was 160 mg/dl (sensitivity 62% and specificity 68%), and 35.2% of the patients had increased levels. This group was elderly, had more prevalence of cardiovascular risk factors, worse renal function and GRACE score as well as more frequently Killip class ≥2. Treatment was similar in both groups besides less frequent use of clopidogrel in high glycaemic patients. The hyperglycaemia group had higher one-year mortality (17.2% vs. 5.6%, p<0.001). Moreover, binary blood glucose remained a predictor of death independently of the GRACE risk score and the presence of diabetes (odds ratio (OR) 1.99, 95% CI 1.40–2.84, p<0.001). The inclusion of blood glucose, as a continuous variable, in a logistic regression model with GRACE score, increased the area under the ROC curve from 0.80 to 0.82 (p=0.018) as well as the goodness-of-fit and was associated with an improvement in both the NRI (37%) and the IDI (0.021), suggesting effective reclassification. Conclusions: A blood glucose level on admission ≥ 160 mg/dl is an independent predictor of mortality in medium-term follow-up. It offers an incremental predictive value when added to the GRACE risk score, although with a modest magnitude of improvement, probably due to the high predictive performance of the GRACE risk score alone.

18 April 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
PBPedro Garcia Brás
Pedro Garcia Brás
SRSílvia Aguiar Rosa
Sílvia Aguiar Rosa
ICIsabel Cardoso
Isabel Cardoso
LBLuísa Moura Branco
Luísa Moura Branco
AGAna Galrinho
Ana Galrinho
LLLuis R Lopes
Luis R Lopes
Background: Two‐dimensional speckle tracking echocardiography has been shown to correlate with microvascular dysfunction, a hallmark of hypertrophic cardiomyopathy (HCM). We hypothesized that there is an association between myocardial work and left ventricular ischemia, with incremental value to global longitudinal strain, in patients with HCM. Methods and Results: We performed a prospective assessment of patients with HCM, undergoing 2‐dimensional speckle tracking echocardiography and stress perfusion cardiac magnetic resonance. Results were stratified according to obstructive or nonobstructive HCM and the presence of significant replacement fibrosis (late gadolinium enhancement ≥15% of left ventricular mass). Seventy‐five patients with HCM (63% men, age 55±15 years) were evaluated, 28% with obstructive HCM (mean gradient 89±60 mm Hg). Perfusion defects were found in 90.7%, involving 22.5±16.9% of left ventricular mass, and 38.7% had late gadolinium enhancement ≥15%. In a multivariable analysis, a lower global work index ( r =−0.519, β‐estimate −10.822; P =0.001), lower global work efficiency ( r =−0.379, β‐estimate −0.123; P =0.041), and impaired global constructive work ( r =−0.532, β‐estimate −13.788; P −15.5%) had a sensitivity of 64% and a specificity of 57%. The association between myocardial work and perfusion defects was significant independently of late gadolinium enhancement ≥15% and obstructive HCM. Conclusions: Impaired myocardial work was significantly correlated with the extent of ischemia in cardiac magnetic resonance, independently of the degree of left ventricular hypertrophy or fibrosis, with a higher predictive power than global longitudinal strain.

1 March 2019 in IJC Heart & Vasculature
Verified
Journal Article
Open access
ATAna Teresa Timóteo
Ana Teresa Timóteo
TMTiago Mendonça
Tiago Mendonça
SRSílvia Aguiar Rosa
Sílvia Aguiar Rosa
AGAntónio Valentim Gonçalves
António Valentim Gonçalves
RCRamiro Carvalho
Ramiro Carvalho
RFRui Cruz Ferreira
Rui Cruz Ferreira
In previous guidelines, acute coronary syndromes (ACS) with new or presumably new left bundle branch block (LBBB) were an indication for reperfusion treatment, preferably with primary angioplasty. Recent guidelines also included the presence of right bundle branch block (RBBB) in this recommendation. It was our objective to evaluate in a population of patients with ACS the differential impact of RBBB and LBBB in prognosis. Consecutive patients included prospectively in a single-centre registry of ACS were included in the study. Patients were analyzed according to baseline ECG characteristics (normal QRS, LBBB or RBBB). Primary outcome was all-cause mortality at one-year follow-up. We used Cox-proportional hazards models to assess the predictive value for the primary outcome. A total of 3990 patients were included in, with a mean age of 64 (13) years, 72% males, 3.4% with LBBB and 4.3% with RBBB. Patients with BBB were older, with more previous history of myocardial infarction and coronary revascularization and higher prevalence of cardiovascular risk factors (except smoking). Medical treatment was similar but they were less often submitted to angioplasty. In univariate analysis, BBB patients had worst outcome (Log-rank, p < 0.001), but similar in LBBB and RBBB (Log-rank, p = 0.597). In multivariate analysis, only RBBB (HR 1.66, 95%CI 1.14-2.40, p = 0.007) is an independent predictor of all-cause mortality. Patients with BBB have worst outcome after an ACS, particularly with RBBB. For that reason, we should pay special attention and treat these patients as aggressively as patients with normal QRS duration or LBBB.

1 October 2018 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
MCMadalena Coutinho Cruz
Madalena Coutinho Cruz
RMRita Ilhão Ilhão Moreira
Rita Ilhão Ilhão Moreira
AAAna Abreu
Ana Abreu
ATAna Teresa Timóteo
Ana Teresa Timóteo
RCRamiro Sá Carvalho
Ramiro Sá Carvalho
RFRui Cruz Ferreira
Rui Cruz Ferreira
Smoking is associated with atherosclerotic disease, but there is controversy about its protective nature after acute coronary syndrome (ACS). To determine the impact of smoking on the presentation, treatment and outcome of ACS. We analyzed all consecutive patients with ACS in a single center between 2005 and 2014. Current smokers and never-smokers were compared. Independent predictors of in-hospital mortality and of a composite of all-cause mortality, rehospitalization for cardiovascular causes, angiography, percutaneous coronary intervention and coronary artery bypass grafting were assessed by multivariate logistic regression. A total of 2727 patients were included, 41.7% current smokers and 58.3% never-smokers. Current smokers were younger, more often male, had fewer comorbidities, a typical clinical presentation, lower heart rate, systolic blood pressure, Killip class, BNP/NT-pro-BNP and creatinine, better left ventricular systolic function and less severe coronary anatomy. ST-segment elevation myocardial infarction was more common in current smokers. Current smokers received more evidence-based treatments and had less in-hospital complications, in-hospital mortality and adverse outcomes at one year. More frequent percutaneous coronary intervention at one year was noted in current smokers. Smoking was not an independent predictor of outcome when the multivariate model was fully adjusted for baseline characteristics. The smoker's paradox was not observed in this population, since all differences in outcome were explained by smokers' more benign baseline characteristics.

19 February 2018 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Open access
PDF file
RMRita Ilhão Ilhão Moreira
Rita Ilhão Ilhão Moreira
PCPedro Silva Cunha
Pedro Silva Cunha
PRPedro Rio
Pedro Rio
MSManuel Nogueira da Silva
Manuel Nogueira da Silva
LBLuísa Moura Branco
Luísa Moura Branco
MOMário Martins Oliveira
Mário Martins Oliveira
Renal dysfunction is often associated with chronic heart failure, leading to increased morbi-mortality. However, data regarding these patients after cardiac resynchronization therapy (CRT) is sparse. We sought to evaluate response and long-term mortality in patients with heart failure and renal dysfunction and assess renal improvement after CRT.

4 August 2008 in EP Europace
Verified
Journal Article
Open access
PDF file
ATAna Teresa Timoteo
Ana Teresa Timoteo
MOMário Martins Oliveira
Mário Martins Oliveira
JFJoana Feliciano
Joana Feliciano
EAEduardo Antunes
Eduardo Antunes
MSManuel Nogueira da Silva
Manuel Nogueira da Silva
RFRui Ferreira
Rui Ferreira
Protocols using sublingual nitrates have been increasingly used to improve diagnostic accuracy of head-up tilt testing (HUT). Nevertheless, exaggerated responses to nitrates have been frequently described, particularly in elderly patients. The aim of this article is to evaluate, in an elderly population with unexplained syncope, whether the impact of sublingual nitroglycerin (NTG) used as a provocative agent is dose-dependent. One hundred and twenty consecutive elderly patients submitted to HUT using NTG after an asymptomatic drug-free phase were studied. Patients were divided into three groups according to the NTG dosage: 500, 375 and 250 µg. The test was considered positive when there was reproduction of symptoms with bradycardia and/or arterial hypotension. A gradual decrease in the blood pressure after NTG was considered an exaggerated response to nitrates. There were no differences in the clinical characteristics of the different subgroups. A positive test was obtained in 50% of the patients in each group. The rate of exaggerated responses was identical in all groups and ranged between 15 and 17%. In an elderly population with syncope of unknown origin submitted to HUT, the response to NTG is not dose-dependent, and no difference was found in the rate of exaggerated responses to nitrates with different NTG dosages.